Southern Star Research Institute LLC | San Antonio, TX
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered Janus kinase 1 inhibitor, in adult participants with Crohn's Disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For Substudy 1:
For Substudy 2:
Exclusion criteria
For Substudies 1 and 2:
Primary purpose
Allocation
Interventional model
Masking
747 participants in 9 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal